Ispecimen Inc. · NASDAQ:ISPC
Ispecimen — Investor Presentation (May 2024)
31 slides from Ispecimen's investor presentation, May 7, 2024
Slide 1: May 2024 Investor Presentation
May 2024 Investor Presentation Nasdaq: ISPC The Online Marketplace for Human Biospecimens Transforming Biospecimen Procurement
Slide 2: Forward-looking statements
This presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “w
Slide 3: Our Vision
Our Vision To transform the biospecimen industry with an online marketplace connecting researchers to patients, biospecimens, and data, through our global network. 3
Slide 4: Investor Highlights
4 1. Similar to Amazon, iSpecimen has developed an online marketplace to seamlessly connect researchers with healthcare providers and supplier organizations 2. First mover advantage that addresses an inefficient and fragmented global biospecimen supply chain that is poised to be disrupted by an onli
Slide 5: Biospecimens are Essential for Life Science R&D
Biospecimens are Essential for Life Science R&D Basic Research Biomarker Identification & Validation Drug Discovery & Development Diagnostics Discovery & Validation Biofluids Solid Tissue Stem & Immune Cells Plasma, Serum, Urine, Saliva Industry Academia Government 5 Lung, Breast, Colon, Brain Bone
Slide 6: Biospecimen Supply Chain Challenges
Biospecimen Supply Chain Challenges Providers miss revenue and research opportunities > 3 Billion clinical specimens are discarded annually worldwide 4 > 1 Billion Patient encounters yearly in the U.S. where a specimen could be provided for research 3 > 800 Million banked specimens are in bioreposit
Slide 7: Biospecimen Supply Chain Challenges
Biospecimen Supply Chain Challenges 7 -Difficult to Connect, Search and Compliantly Transact -Average time to develop relationships is 6-12 months ᶟ PROVIDERS CHALLENGE RESEARCHERS
Slide 8: iSpecimen Marketplace | Approach
iSpecimen Marketplace | Approach Demand Side Life Science Researchers Supply Side Providers
Slide 9: Full-Service Procurement Offering
Full-Service Procurement Offering -Connect Suppliers with Researchers -Manage the Entire Procurement Process SPECIMEN SEARCH & SELECTION SPECIMEN LOGISTICS SPECIMEN MANAGEMENT DATA MANAGEMENT STUDY/ORDER MANAGEMENT SUPPLIER SITE TRAINING COLLECTION KIT BUILDING COMPLIANCE MANAGEMENT STUDY DESIGN & S
Slide 10: iSpecimen Value Proposition
Advance Scientific Discovery Support research mission and advance diagnostic, therapeutic and vaccine research Monetize Banked Biospecimens Instantly connect to a global network of researchers in search for biospecimens Ensure Compliance Protect the privacy and security of patient information Accele
Slide 11: Agreements with 140+ Supplier Organizations
11 Agreements with 140+ Supplier Organizations ✔ Hospitals ✔ Clinics and Practice Groups ✔ Clinical Research Centers ✔ Clinical and Pathology Labs ✔ Biorepositories ✔ Blood Centers Growing Researcher Adoption ✔ 600+ Buyside Customers ✔ Work with 70% of Top-20 Pharma and IVD Companies in the World ✔
Slide 12: Strategic Growth Initiatives
Strategic Growth Initiatives 12
Slide 13: Enhance iSpecimen Marketplace Technology
Enhance iSpecimen Marketplace Technology 13 Increased investment and ongoing advancements of iSpecimen Marketplace technology would enable: ● Improved integration with provider partners (our first patient data electronic record integrations) ● Improved iSpecimen Marketplace search and request capabi
Slide 14: iSpecimen Product Roadmap
iSpecimen Product Roadmap* Revamp Customer Search Experience, Unify data, and Automate Matchmaking Enhance Supplier Experience though enablement, reporting and workflow. Expand Prospective search capabilities Continue to evolve Efficiencies, Matchmaking and Data. *iSpecimen will continue product evo
Slide 15: Capitalize on Growing Data Asset
“Utilization of sample data for research and for monetization is the next key value driver for the biobanks.” - Frost & Sullivan, Global Biobanking Market Landscape Capitalize on Growing Data Asset Banked Specimen Records Patient Records Medical Condition Records Clinical Specimen Records Laboratory
Slide 16: Financial Overview
| QISPECIMEN 2 Financial Overview 16
Slide 17: Annual Revenue 2015 – 2023
$700 $1,448 $3,067 $4,395 $4,298 $8,184 $11,135 $10,402 $9,928 $2,290 2015 2016 2017 2018 2019 2020 2021 2022 2023 Q1 2024 Annual Revenue ($1,000) 2015 – 2023 ▲ 39% CAGR Revenue (2015 – 2023) Annual Revenue 17
Slide 18: Statement of Operations
Statement of Operations 18 iSpecimen Inc. Condensed Statement of Operations Three months ended March 31, 2024 2023 (unaudited) (unaudited) Revenue $2,289,993 $2,950,197 Operating expenses: Cost of revenue 1,000,006 1,146,912 Technology 911,967 834,407 Sales and marketing 665,941 962,169 Supply devel
Slide 19: Balance Sheet
Balance Sheet 19 iSpecimen Inc. Condensed Balance Sheet Information March 31, 2024 December 31, 2023 ASSETS Cash $2,089,891 $2,343,666 Investments-short term 466,493 2,661,932 Accounts receivable - unbilled 1,978,144 2,212,538 Accounts receivable, net of allowance for doubtful accounts 437,424 728,3
Slide 20: Common Stock Information
Common Stock Information 20 iSpecimen Inc. Fully Diluted Shares Outstanding Diluted Shares of Common Stock Shares outstanding at March 31, 2024 9,470,112 Shares issuable upon vesting of RSUs 96,788 Shares issuable upon exercise of stock options 350,062 Shares issuable upon exercise of warrant to pur
Slide 21: Tracy Curley, Chief Executive Officer
Tracy Curley | Chief Executive Officer, Chief Financial Officer and Treasurer Ms. Curley brings three decades of experience in public accounting and corporate finance for both publicly traded companies and emerging companies like iSpecimen and joined iSpecimen in August 2020. She came to iSpecimen a
Slide 22: Investor Highlights
2 2 1. Similar to Amazon, iSpecimen has developed an online marketplace to seamlessly connect researchers with healthcare providers and supplier organizations 2. First mover advantage that addresses an inefficient and fragmented global biospecimen supply chain that is poised to be disrupted by an on
Slide 23: Be a part of the biospecimen revolution
Sign up for a free iSpecimen Marketplace account at iSpecimen.com Contact us. iSpecimen Inc. 450 Bedford Street Lexington, MA 02420 investors@ispecimen.com Be a part of the biospecimen revolution
Slide 24: Appendix
Appendix 24
Slide 25: Strategic Evolution
PHASE 3 Expansion via the Online iSpecimen Marketplace START UP Company Ideation and Self-Funding PHASE 1 Proof of Concept PHASE 2 Critical Mass of Suppliers and Early Customer Adoption 🡡 🡡 2010 – 2011 2012 – 2013 2014 – 2017 2018 – 2024 0 Customers 1 Supplier Agreement 0 Specimen Records 0…
Slide 26: iSpecimen Marketplace UI/UX
iSpecimen Marketplace UI/UX Click Search to start searching for specimens 26
Slide 27: iSpecimen Marketplace UI/UX
2 7 iSpecimen Marketplace UI/UX Use search bar to quickly find specimens that match search criteria
Slide 28: Refine Search Results Using Sliders and Check Boxes
Refine Search Results Using Sliders and Check Boxes iSpecimen Marketplace UI/UX 28
Slide 29: View Quote Request and Add More Specimens
View Quote Request and Add More Specimens Request a Quote iSpecimen Marketplace UI/UX 29 Track and Manage Requests
Slide 30: Sources Cited
30 Page Note Source Cited 4 1 iSpecimen estimates based on In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics) By End-use, By Region, And Segment Forecasts, 2021 – 2027. Grandview Research, January 2021;
Slide 31: iSpecimen Marketplace
@ iSPECIMEN Marketplace